BOPA Equity, Diversity and Inclusion (EDI) Code of Conduct Policy and Policy Statement

BOPA is committed to building a diverse, equitable and inclusive community for all members, non-members and patients in cancer care.  The British Oncology Pharmacy Association (BOPA) has produced a code of conduct for all BOPA members, to promote a culture of equity, diversity and inclusion (EDI) within the organisation.  We have also produced BOPA Policy Statement for Equity, Diversity and Inclusion.

This information can be found on the EDI Subcommittee page here: https://www.bopa.org.uk/membergroups/subcommittee/equality-diversity-and-inclusion-sub-committee/ or via the resource section here: https://www.bopa.org.uk/resources/?_sft_resource-tags=equity-diversity-and-inclusion-subcommittee

 

Latest News

By Suriya Marshall on 14th March 2026

Parliamentary Intervention Sparks National Campaign to Protect NHS Staff from Hazardous Medicinal Products (HMPs)

First UK Campaign to Protect Healthcare Workers from Exposure to Hazardous Medicinal Products (HMPs) launches in Westminster London, 10 March 2026: Today, the Safer Healthcare and Biosafety Network (SHBN) launches…

Read article
By Suriya Marshall on 14th March 2026

Clinical Pharmacy Congress. 8th-9th May 2026

Dear BOPA member, We are excited to announce that we have partnered with Clinical Pharmacy Congress 2026. Clinical Pharmacy Congress is the UK’s leading event for clinical pharmacy professionals working across…

Read article
By BOPA Executive Committee on 13th March 2026

First UK Campaign to Protect Healthcare Workers from Exposure to Hazardous Medicinal Products (HMPs) launches in Westminster

London, 10 March 2026: The Safer Healthcare and Biosafety Network (SHBN) launches a new campaign titled “Protecting Healthcare Workers: Safer Handling of Hazardous Medicinal Products” to raise awareness of the dangers…

Read article
By BOPA on 13th March 2026

Invitation to Participate: SWEET-PLUS Study

You are invited to take part in a research study called SWEET-PLUS (NIHR Research for Patient Benefit: 207952), run by Newcastle and Oxford Brookes Universities. SWEET-PLUS aims to understand experiences…

Read article